Development of an intein-mediated split–Cas9 system for gene therapy

Using CRISPR/Cas9, it is possible to target virtually any gene in any organism. A major limitation to its application in gene therapy is the size of Cas9 (>4 kb), impeding its efficient delivery via recombinant adeno-associated virus (rAAV). Therefore, we developed a split–Cas9 system, bypassing the packaging limit using split-inteins. Each Cas9 half was fused to the corresponding split-intein moiety and, only upon co-expression, the intein-mediated trans-splicing occurs and the full Cas9 protein is reconstituted. We demonstrated that the nuclease activity of our split-intein system is comparable to wild-type Cas9, shown by a genome-integrated surrogate reporter and by targeting three different endogenous genes. An analogously designed split-Cas9D10A nickase version showed similar activity as Cas9D10A. Moreover, we showed that the double nick strategy increased the homologous directed recombination (HDR). In addition, we explored the possibility of delivering the repair template accommodated on the same dual-plasmid system, by transient transfection, showing an efficient HDR. Most importantly, we revealed for the first time that intein-mediated split–Cas9 can be packaged, delivered and its nuclease activity reconstituted efficiently, in cells via rAAV.

[1]  Kira S. Makarova,et al.  Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems , 2013, Nucleic acids research.

[2]  Chandra Sekhar Pedamallu,et al.  Faster Protein Splicing with the Nostoc punctiforme DnaE Intein Using Non-native Extein Residues , 2013, The Journal of Biological Chemistry.

[3]  W. Wurst,et al.  Highly Efficient Targeted Mutagenesis in Mice Using TALENs , 2013, Genetics.

[4]  Nicholas E. Propson,et al.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis , 2013, Proceedings of the National Academy of Sciences.

[5]  Randall J. Platt,et al.  Optical Control of Mammalian Endogenous Transcription and Epigenetic States , 2013, Nature.

[6]  B. Wang,et al.  Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. , 2008, Human Gene Therapy.

[7]  Jennifer A. Doudna,et al.  Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation , 2014, Science.

[8]  Feng Zhang,et al.  A split-Cas9 architecture for inducible genome editing and transcription modulation , 2015, Nature Biotechnology.

[9]  Benjamin L. Oakes,et al.  Programmable RNA recognition and cleavage by CRISPR/Cas9 , 2014, Nature.

[10]  Christopher A. Voigt,et al.  Principles of genetic circuit design , 2014, Nature Methods.

[11]  Jeffrey J. Tabor,et al.  Post-translational tools expand the scope of synthetic biology. , 2012, Current opinion in chemical biology.

[12]  M. Ehlers,et al.  Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. , 2011, Human gene therapy.

[13]  Amy B Tyszkiewicz,et al.  Activation of protein splicing with light in yeast , 2008, Nature Methods.

[14]  W. Wurst,et al.  Creation of targeted genomic deletions using TALEN or CRISPR/Cas nuclease pairs in one-cell mouse embryos , 2014, FEBS open bio.

[15]  Prashant Mali,et al.  Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing , 2013, Nature Methods.

[16]  L. Vandenberghe,et al.  Adeno-associated virus: fit to serve. , 2014, Current opinion in virology.

[17]  W. Wurst,et al.  Reversible and tissue‐specific activation of MAP kinase signaling by tamoxifen in brafV637ERT2 mice , 2013, Genesis.

[18]  T. Muir,et al.  Kinetic control of one-pot trans-splicing reactions by using a wild-type and designed split intein. , 2011, Angewandte Chemie.

[19]  S. Mittal,et al.  Adenoviral vector immunity: its implications and circumvention strategies. , 2011, Current gene therapy.

[20]  K. Dill.  Theory for the folding and stability of globular proteins. , 1985, Biochemistry.

[21]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[22]  T. Muir,et al.  Protein splicing triggered by a small molecule. , 2002, Journal of the American Chemical Society.

[23]  M. Isalan,et al.  A split intein T7 RNA polymerase for transcriptional AND-logic , 2014, Nucleic acids research.

[24]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[25]  J. Keith Joung,et al.  FLASH Assembly of TALENs Enables High-Throughput Genome Editing , 2012, Nature Biotechnology.

[26]  Daniel J. Rader,et al.  Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing , 2014, Circulation research.

[27]  Ryan R. Richardson,et al.  Two- and three-input TALE-based AND logic computation in embryonic stem cells , 2013, Nucleic acids research.

[28]  Yarden Katz,et al.  Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system , 2013, Cell Research.

[29]  Dominik Niopek,et al.  CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. , 2014, Biotechnology journal.

[30]  Ulrike Winkler,et al.  Split-CreERT2: Temporal Control of DNA Recombination Mediated by Split-Cre Protein Fragment Complementation , 2009, PloS one.

[31]  Tom W Muir,et al.  Post-translational enzyme activation in an animal via optimized conditional protein splicing. , 2007, Nature chemical biology.

[32]  Hao Yin,et al.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.

[33]  V. Iyer,et al.  Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects , 2014, Nature Methods.

[34]  L A Herzenberg,et al.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Ethan Bier,et al.  The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations , 2015, Science.

[36]  F. Mingozzi,et al.  Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions , 2014, Front. Immunol..

[37]  David Bryder,et al.  Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. , 2014, Cell stem cell.

[38]  Samuel H Sternberg,et al.  Rational design of a split-Cas9 enzyme complex , 2015, Proceedings of the National Academy of Sciences.

[39]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.

[40]  W. Wurst,et al.  Modeling disease mutations by gene targeting in one-cell mouse embryos , 2012, Proceedings of the National Academy of Sciences.

[41]  A. Nordheim,et al.  Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase. , 2014, Cardiovascular research.

[42]  P. Lyu,et al.  Circular Permutation Prediction Reveals a Viable Backbone Disconnection for Split Proteins: An Approach in Identifying a New Functional Split Intein , 2012, PloS one.

[43]  Jeffry D Sander,et al.  FLAsH assembly of TALeNs for high-throughput genome editing , 2022 .

[44]  Feng Zhang,et al.  Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.